What is Proficient Rx?
Proficient Rx specializes in providing point-of-care medication and dispensing programs tailored for a wide array of licensed healthcare providers. The company's core offering involves prepackaging, labeling, and distributing ready-to-dispense medications directly to medical practices and clinics. Proficient Rx ensures the highest quality, FDA-approved medications in unit-of-use quantities, repackaged within its VAWD accredited, DEA and FDA approved facility. Each product undergoes an rigorous 18-step quality control process, guaranteeing purity, safety, and traceability. The company possesses the capability to package all legend drugs and controlled substances, including Schedules 2, 3, 3N, 4, and 5, alongside OTCs, vitamins, and nutraceuticals.
How much funding has Proficient Rx raised?
Proficient Rx has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Proficient Rx
PPP
Public-Private Partnership
What's next for Proficient Rx?
The substantial enterprise-level backing and recent strategic investment position Proficient Rx for accelerated expansion and innovation in the healthcare technology and pharmaceutical services market. This capital infusion is expected to fuel advancements in their dispensing technology, enhance operational capacity, and broaden their market reach to more healthcare providers. Proficient Rx's commitment to quality control and regulatory compliance, evidenced by their VAWD accreditation and FDA/DEA approvals, provides a strong foundation for future growth and strategic partnerships within the evolving landscape of patient care and medication management.
See full Proficient Rx company page
